{"id":37866,"date":"2025-01-03T10:40:28","date_gmt":"2025-01-03T07:40:28","guid":{"rendered":"https:\/\/massivebio.com\/?p=37866"},"modified":"2025-10-01T11:34:24","modified_gmt":"2025-10-01T08:34:24","slug":"selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase","status":"publish","type":"post","link":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/","title":{"rendered":"Selin Kurnaz Brings Cancer Patients Together with Drugs in the Trial Phase"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>Massive Bio, which matches patients with new cancer drugs in clinical trials, has so far received $23 million in investment from investors including IFC and the German Development Bank (DEG). Founder Selin Kurnaz aims to re-evaluate molecules abandoned by pharmaceutical companies before completing their development stage, in order to make new discoveries.<\/p>\n<p>While explaining the importance of Massive Bio, which she founded, for both pharmaceutical companies and cancer patients, Selin Kurnaz says: \u201cIf your mother had cancer, the first person you would call is me, not Elon Musk. Cancer is the largest and fastest-growing market, which is why it\u2019s the best market from an investment perspective.\u201d<\/p>\n<p>Before the unsettling effect of these words fades, she adds an even sharper remark: \u201cIn the future, one out of every three of us will have cancer. As investors, we want to act early in this field.\u201d<\/p>\n<p>Kurnaz, who founded U.S.-based Massive Bio in 2015 together with two partners (\u00c7a\u011fatay \u00c7ulcuo\u011flu and Arturo Loaiza-Bonilla), connects cancer patients from all over the world with clinical trials of newly developed cancer drugs. The three co-founders aim to transform the company into a next-generation pharmaceutical company within five years.<\/p>\n<p>By Erkan K\u0131z\u0131locak<\/p>\n<p><strong>Disclaimer:<\/strong> This is an English translation of an article originally published in Forbes T\u00fcrkiye. The original Turkish article can be found here:<br \/>\n<a href=\"https:\/\/www.forbes.com.tr\/dergi\/selin-kurnaz-kanser-hastalariyla-deneme-surecindeki-ilaclari-bulusturuyor\" target=\"_blank\" rel=\"noopener\">https:\/\/www.forbes.com.tr\/dergi\/selin-kurnaz-kanser-hastalariyla-deneme-surecindeki-ilaclari-bulusturuyor<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Massive Bio, which matches patients with new cancer drugs in clinical trials, has so far received $23 million in investment from investors including IFC and the German Development Bank (DEG). Founder Selin Kurnaz aims to re-evaluate molecules abandoned by pharmaceutical companies before completing their development stage, in order to make new discoveries. While explaining the...","protected":false},"author":11,"featured_media":37867,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-37866","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Selin Kurnaz Brings Cancer Patients Together with Drugs in the Trial Phase<\/title>\n<meta name=\"description\" content=\"Massive Bio, which matches patients with new cancer drugs in clinical trials, has so far received $23 million in investment from investors including IFC and the German Development Bank (DEG).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Selin Kurnaz Brings Cancer Patients Together with Drugs in the Trial Phase %\" \/>\n<meta property=\"og:description\" content=\"Massive Bio, which matches patients with new cancer drugs in clinical trials, has so far received $23 million in investment from investors including IFC and the German Development Bank (DEG).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-03T07:40:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-01T08:34:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/Forbes.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"719\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Selin Kurnaz Brings Cancer Patients Together with Drugs in the Trial Phase","description":"Massive Bio, which matches patients with new cancer drugs in clinical trials, has so far received $23 million in investment from investors including IFC and the German Development Bank (DEG).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/","og_locale":"en_US","og_type":"article","og_title":"Selin Kurnaz Brings Cancer Patients Together with Drugs in the Trial Phase %","og_description":"Massive Bio, which matches patients with new cancer drugs in clinical trials, has so far received $23 million in investment from investors including IFC and the German Development Bank (DEG).","og_url":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-01-03T07:40:28+00:00","article_modified_time":"2025-10-01T08:34:24+00:00","og_image":[{"width":960,"height":719,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/Forbes.jpg","type":"image\/jpeg"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Selin Kurnaz Brings Cancer Patients Together with Drugs in the Trial Phase","datePublished":"2025-01-03T07:40:28+00:00","dateModified":"2025-10-01T08:34:24+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/"},"wordCount":256,"commentCount":0,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/Forbes.jpg","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/","url":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/","name":"Selin Kurnaz Brings Cancer Patients Together with Drugs in the Trial Phase","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/Forbes.jpg","datePublished":"2025-01-03T07:40:28+00:00","dateModified":"2025-10-01T08:34:24+00:00","description":"Massive Bio, which matches patients with new cancer drugs in clinical trials, has so far received $23 million in investment from investors including IFC and the German Development Bank (DEG).","breadcrumb":{"@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/Forbes.jpg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/Forbes.jpg","width":960,"height":719,"caption":"Selin Kurnaz Brings Cancer Patients Together with Drugs in the Trial Phase"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/selin-kurnaz-brings-cancer-patients-together-with-drugs-in-the-trial-phase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"Selin Kurnaz Brings Cancer Patients Together with Drugs in the Trial Phase"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/37866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=37866"}],"version-history":[{"count":3,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/37866\/revisions"}],"predecessor-version":[{"id":37889,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/37866\/revisions\/37889"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/37867"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=37866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=37866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=37866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}